A carregar...
Glutamatergic Antipsychotic Drugs: A New Dawn in the Treatment of Schizophrenia?
Growing evidence for glutamate abnormalities in schizophrenia support the development of novel antipsychotic agents targeting this system. Early studies investigating modulation of the glutamate system using glycine, D-serine and sarcosine in patients with schizophrenia have demonstrated significant...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3736896/ https://ncbi.nlm.nih.gov/pubmed/23983922 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045125311400779 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|